Study of Lipoprotein (a) Levels in Patients with Cardiovascular Disease

Clinical Trial Title

Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoprotein (a) levels in patients with established CVD.

Contact Information

Nusrat Jahan

Clinical Trial Protocol Description:

Lipoprotein (a) is now recognized as a causal risk factor for coronary artery disease, stroke, and peripheral artery disease. The purpose of this study is to improve knowledge regarding the epidemiology of Lipoprotein(a) in patients with established cardiovascular disease (CVD). Relevant demographic data, medical history, and laboratory values for LDL-cholesterol and Lp(a) will be collected retrospectively. In the event that laboratory data is not available blood sampling will be performed.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Are between 18 and 80 years of age.
  • Have established cardiovascular disease (CVD) defined as one of the following:
    • Have a history of a myocardial infarction (MI).
    • Have a history of ischemic stroke.
    • Have symptomatic PAD.

You will be excluded from the study if any of the following criteria apply to you:

  • Are enrolled in a clinical study with investigational drugs.

This is a partial list of inclusion and exclusion criteria. To inquire about your eligibility, please call the contact number provided.

Study Details

Clinical Trial Investigator

Annabelle S. Volgman, MD

Contact Information

Nusrat Jahan

(312) 942-1630


Rush University Medical Center

1620 W Harrison St
Chicago, IL 60612

Get Directions

Clinical Trial FAQs

Find out if a clinical trial makes sense for you.

Learn more
Learn more